The Effect of Hydration Status on Substrate Oxidation at Rest and During Light and Moderate Exercise

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorPepsiCo Global R&D

About this trial

Metabolic flexibility is the ability to properly switch between fat and carbohydrate stores to use for energy under different conditions (rest, feeding, exercise). Impairments in metabolic flexibility, also known as metabolic inflexibility, have been suggested to be an underlying cause of metabolic disease, like type 2 diabetes. Long-term low fluid intake may increase the risk of type 2 diabetes due to insulin resistance, a form of metabolic inflexibility. Further, low fluid intake has been shown to impair the ability to switch fuel preference during exercise.

While there is some evidence that low fluid intake may lead to impaired metabolic flexibility, more information is needed. Therefore, the purpose of this study is to evaluate the impact of hydration status on substrate preference at rest and during exercise at varying intensities (light and moderate). Further, we will examine whether biological sex and menstrual cycle phase impact hydration and metabolism under these same conditions.

Eligibility criteria

Qualifiers

Subject is male or female

If female, subject is not pregnant (based on self-report)

If female, subject has stopped taking birth control medication or removed long-acting reversible contraceptive >6 months at start of the study

If female, subject has normal menstrual cycle (21-35 days)

Disqualifiers

Subject has participated in a clinical trial within the past 30 days

Subject has participated in any PepsiCo trial within past 36 months

Subject has a condition or is taking medication that the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results, or put the person at undue risk

Subject is allergic to alcohol (alcohol pre pads are used for blood draws

Trial design

Treatments tested in this trial

  • Exercise Trial
  • Experimental Trial

Treatment groups

74 Participants
are divided into 3 treatment groups

Sponsors and collaborators